Managing and Supporting Surgery in Patients with Bleeding Disorders

被引:5
作者
Curnow, Jennifer [1 ,2 ]
机构
[1] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Clin & Lab Hematol, Sydney Ctr Thrombosis, Westmead, NSW, Australia
[2] Westmead Hosp, Inst Clin Pathol & Med Res, Dept Clin & Lab Hematol, Sydney Ctr Haemostasis, Westmead, NSW, Australia
关键词
inherited bleeding disorders; acquired bleeding disorders; perioperative management; factor concentrates; thromboprophylaxis; VON-WILLEBRAND-DISEASE; RECOMBINANT FACTOR VIIA; PRIMARY IMMUNE THROMBOCYTOPENIA; CENTER DOCTORS ORGANIZATION; PLATELET-FUNCTION DISORDERS; SEVERE HEMOPHILIA-A; MAJOR ORTHOPEDIC-SURGERY; FACTOR-V INHIBITORS; VENOUS THROMBOEMBOLISM; ACQUIRED HEMOPHILIA;
D O I
10.1055/s-0037-1605568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with inherited bleeding disorders are likely to require surgery at various times throughout life. In some cases, this may be major orthopaedic surgery required due to their underlying condition, for example, hemophilic arthropathy. For inherited disorders with significant bleeding risk, surgery should take place in a hemophilia treatment center with the availability of hematologic, anesthetic, surgical, nursing, scientific laboratory, and allied health expertise. Preoperative assessment, planning, and communication between team members are crucial. Specific replacement therapy is usually required, as may other adjunctive therapies. Venous thromboembolism (VTE) risk assessment is individualized, taking account of other underlying risks in the patient and risks associated with the procedure, including the replacement agent itself, and use of mechanical prophylaxis may be the safest approach in many cases. Pain management is also modified to take account of risks associated with the bleeding disorder, and spinal or epidural analgesia is restricted compared with patients who do not have hemostatic defects. In patients with acquired bleeding disorders, the preoperative assessment includes decisions regarding how best to optimize management of the underlying condition prior to proceeding with surgery. If this is achieved, specific replacement therapy may not be required. If complete remission of the acquired bleeding disorder is achieved preoperatively, then VTE prophylaxis and pain management options will not be limited by the bleeding disorder. The perioperative management of both hereditary and acquired bleeding disorders is discussed and contrasted.
引用
收藏
页码:653 / 671
页数:19
相关论文
共 150 条
[1]  
Aglietti P, 2000, CLIN ORTHOP RELAT R, P169
[2]   Modern management of severe platelet function disorders [J].
Alamelu, Jayanthi ;
Liesner, Ri .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (06) :813-823
[3]   MYH9-Related Platelet Disorders [J].
Althaus, Karina ;
Greinacher, Andreas .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (02) :189-203
[4]   Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura [J].
Arnold, Donald M. ;
Dentali, Francesco ;
Crowther, Mark A. ;
Meyer, Ralph M. ;
Cook, Richard J. ;
Sigouin, Christopher ;
Fraser, Graeme A. ;
Lim, Wendy ;
Kelton, John G. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (01) :25-W5
[6]   Hetastarch and bleeding complications after coronary artery surgery [J].
Avorn, J ;
Patel, M ;
Levin, R ;
Winkelmayer, WC .
CHEST, 2003, 124 (04) :1437-1442
[7]   Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease [J].
Batlle, Javier ;
Fernanda Lopez-Fernandez, Maria ;
Loures Fraga, Esther ;
Rodriguez Trillo, Angela ;
Almudena Perez-Rodriguez, Maria .
BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) :89-100
[8]   Intermittent injections vs. continuous infusion of Factor VIII in haemophilia patients undergoing major surgery [J].
Batorova, A ;
Martinowitz, U .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :715-720
[9]   Cardiac bypass haemostasis: Putting blood through the mill [J].
Bevan, DH .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) :208-219
[10]  
Björkman S, 2001, CLIN PHARMACOKINET, V40, P815